TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs12073837
log Bayes Factor = <0.0001
Chromosome 1   position 221,010,205  (GRCh37) Explore rs12073837 on Ensembl!
Variant rs12073837 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
M47.86 Other spondylosis (Lumbar region)
0.000 0.940 0.060
M47.8 Other spondylosis
0.000 0.944 0.056
M47.9 Spondylosis, unspecified
0.000 0.946 0.054
M47.92 Spondylosis, unspecified (Cervical region)
0.000 0.947 0.053
M47 Spondylosis
0.000 0.947 0.053
M47.97 Spondylosis, unspecified (Lumbosacral region)
0.000 0.948 0.052
M47.80 Other spondylosis (Multiple sites in spine)
0.000 0.951 0.049
M47.87 Other spondylosis (Lumbosacral region)
0.000 0.953 0.047
M47.2 Other spondylosis with radiculopathy
0.000 0.958 0.042
M47.81 Other spondylosis (Occipito-atlanto-axial region)
0.000 0.960 0.040
M47.1 Other spondylosis with myelopathy
0.000 0.961 0.039
M47.93 Spondylosis, unspecified (Cervicothoracic region)
0.000 0.961 0.039
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)
0.000 0.961 0.039
M47.99 Spondylosis, unspecified (Site unspecified)
0.000 0.961 0.039
M47.85 Other spondylosis (Thoracolumbar region)
0.000 0.961 0.039
M47.83 Other spondylosis (Cervicothoracic region)
0.000 0.961 0.039
M47.84 Other spondylosis (Thoracic region)
0.000 0.961 0.039
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)
0.000 0.961 0.038
M47.0 Anterior spinal and vertebral artery compression syndromes
0.000 0.962 0.038
M47.94 Spondylosis, unspecified (Thoracic region)
0.000 0.962 0.038
M47.95 Spondylosis, unspecified (Thoracolumbar region)
0.000 0.962 0.038
M47.96 Spondylosis, unspecified (Lumbar region)
0.000 0.964 0.036
M47.89 Other spondylosis (Site unspecified)
0.000 0.966 0.034
M47.88 Other spondylosis (Sacral and sacrococcygeal region)
0.000 0.966 0.034
M47.90 Spondylosis, unspecified (Multiple sites in spine)
0.000 0.966 0.034
M47.26 Other spondylosis with radiculopathy (Lumbar region)
0.000 0.966 0.034
M47.22 Other spondylosis with radiculopathy (Cervical region)
0.000 0.967 0.033
M47.12 Other spondylosis with myelopathy (Cervical region)
0.000 0.969 0.031
M47.29 Other spondylosis with radiculopathy (Site unspecified)
0.000 0.970 0.030
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)
0.000 0.970 0.030
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)
0.000 0.970 0.030
M47.24 Other spondylosis with radiculopathy (Thoracic region)
0.000 0.970 0.030
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)
0.000 0.970 0.030
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)
0.000 0.970 0.030
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)
0.000 0.970 0.030
M47.19 Other spondylosis with myelopathy (Site unspecified)
0.000 0.972 0.028
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)
0.000 0.972 0.028
M47.17 Other spondylosis with myelopathy (Lumbosacral region)
0.000 0.972 0.028
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)
0.000 0.972 0.028
M47.14 Other spondylosis with myelopathy (Thoracic region)
0.000 0.972 0.028
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)
0.000 0.972 0.028
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)
0.000 0.972 0.028
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)
0.000 0.972 0.028
M47.09 Anterior spinal and vertebral artery compression syndromes (Site unspecified)
0.000 0.972 0.027
M47.08 Anterior spinal and vertebral artery compression syndromes (Sacral and sacrococcygeal region)
0.000 0.972 0.027
M47.07 Anterior spinal and vertebral artery compression syndromes (Lumbosacral region)
0.000 0.972 0.027
M47.06 Anterior spinal and vertebral artery compression syndromes (Lumbar region)
0.000 0.972 0.027
M47.05 Anterior spinal and vertebral artery compression syndromes (Thoracolumbar region)
0.000 0.972 0.027
M47.04 Anterior spinal and vertebral artery compression syndromes (Thoracic region)
0.000 0.972 0.027
M47.03 Anterior spinal and vertebral artery compression syndromes (Cervicothoracic region)
0.000 0.972 0.027
M47.02 Anterior spinal and vertebral artery compression syndromes (Cervical region)
0.000 0.972 0.027
M47.01 Anterior spinal and vertebral artery compression syndromes (Occipito-atlanto-axial region)
0.000 0.972 0.027
M47.00 Anterior spinal and vertebral artery compression syndromes (Multiple sites in spine)
0.000 0.972 0.027
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)
0.000 0.972 0.027
M47.82 Other spondylosis (Cervical region)
0.000 0.973 0.027
M47.16 Other spondylosis with myelopathy (Lumbar region)
0.000 0.973 0.026
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters
0.000 0.983 0.017
Z99.3 Dependence on wheelchair
0.000 0.984 0.016
T83.0 Mechanical complication of urinary (indwelling) catheter
0.011 0.989 0.000
G95.2 Cord compression, unspecified
0.010 0.990 0.000
T83 Complications of genito-urinary prosthetic devices, implants and grafts
0.010 0.990 0.000
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system
0.010 0.990 0.000
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts
0.010 0.990 0.000
T83.3 Mechanical complication of intra-uterine contraceptive device
0.008 0.992 0.000
T83.2 Mechanical complication of graft of urinary organ
0.008 0.992 0.000
T83.9 Unspecified complication of genito-urinary prosthetic device, implant and graft
0.008 0.992 0.000
T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract
0.008 0.992 0.000
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract
0.008 0.992 0.000
G95.9 Disease of spinal cord, unspecified
0.007 0.993 0.000
G95 Other diseases of spinal cord
0.007 0.993 0.000
D32.9 Meninges, unspecified
0.007 0.993 0.000
D41.0 Kidney
0.006 0.994 0.000
C81.9 Hodgkin's disease, unspecified
0.006 0.994 0.000
Z75.1 Person awaiting admission to adequate facility elsewhere
0.006 0.994 0.000
G95.1 Vascular myelopathies
0.005 0.995 0.000
D32.1 Spinal meninges
0.005 0.995 0.000
G95.0 Syringomyelia and syringobulbia
0.005 0.995 0.000
D32 Benign neoplasm of meninges
0.005 0.995 0.000
Z42.0 Follow-up care involving plastic surgery of head and neck
0.005 0.995 0.000
Y86 Sequelae of other accidents
0.005 0.995 0.000
G61.0 Guillain-Barre syndrome
0.005 0.995 0.000
I45.5 Other specified heart block
0.005 0.995 0.000
C81 Hodgkin's disease
0.005 0.995 0.000
S62.50 Fracture of thumb (closed)
0.005 0.995 0.000
M49.54 Collapsed vertebra in diseases classified elsewhere (Thoracic region)
0.000 0.995 0.005
C81.1 Nodular sclerosis
0.004 0.995 0.000
S61.1 Open wound of finger(s) with damage to nail
0.005 0.995 0.000
D63.0 Anaemia in neoplastic disease
0.004 0.996 0.000
I86.1 Scrotal varices
0.004 0.996 0.000
G95.8 Other specified diseases of spinal cord
0.004 0.996 0.000
M45-M49 Spondylopathies
0.000 0.996 0.004
M49.5 Collapsed vertebra in diseases classified elsewhere
0.000 0.996 0.004
M49 Spondylopathies in diseases classified elsewhere
0.000 0.996 0.004
I78.1 Naevus, nonneoplastic
0.000 0.996 0.004
H34.8 Other retinal vascular occlusions
0.000 0.996 0.004
D32.0 Cerebral meninges
0.004 0.996 0.000
Z75 Problems related to medical facilities and other health care
0.004 0.996 0.000
Z75.8 Other problems related to medical facilities and other health care
0.004 0.996 0.000
C81.0 Lymphocytic predominance
0.004 0.996 0.000
C81.7 Other Hodgkin's disease
0.004 0.996 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.004 0.996 0.000
C81.3 Lymphocytic depletion
0.004 0.996 0.000
T83.1 Mechanical complication of other urinary devices and implants
0.003 0.996 0.000
Z75.4 Unavailability and inaccessibility of other helping agencies
0.004 0.996 0.000
I45 Other conduction disorders
0.004 0.996 0.000
C81.2 Mixed cellularity
0.003 0.996 0.000
S62.51 Fracture of thumb (open)
0.003 0.996 0.000
S62.5 Fracture of thumb
0.004 0.996 0.000
T78.1 Other adverse food reactions, not elsewhere classified
0.004 0.996 0.000
I45.3 Trifascicular block
0.003 0.997 0.000
G61.8 Other inflammatory polyneuropathies
0.003 0.997 0.000
T78.4 Allergy, unspecified
0.003 0.997 0.000
G61 Inflammatory polyneuropathy
0.003 0.997 0.000
W25.9 Unspecified place
0.003 0.997 0.000
H57.8 Other specified disorders of eye and adnexa
0.000 0.997 0.003
J92.9 Pleural plaque without asbestos
0.000 0.997 0.003
C91.5 Adult T-cell leukaemia
0.003 0.997 0.000
M96.0 Pseudarthrosis after fusion or arthrodesis
0.003 0.997 0.000
M49.59 Collapsed vertebra in diseases classified elsewhere (Site unspecified)
0.000 0.997 0.003
M49.58 Collapsed vertebra in diseases classified elsewhere (Sacral and sacrococcygeal region)
0.000 0.997 0.003
M49.57 Collapsed vertebra in diseases classified elsewhere (Lumbosacral region)
0.000 0.997 0.003
M49.55 Collapsed vertebra in diseases classified elsewhere (Thoracolumbar region)
0.000 0.997 0.003
M49.53 Collapsed vertebra in diseases classified elsewhere (Cervicothoracic region)
0.000 0.997 0.003
M49.52 Collapsed vertebra in diseases classified elsewhere (Cervical region)
0.000 0.997 0.003
M49.51 Collapsed vertebra in diseases classified elsewhere (Occipito-atlanto-axial region)
0.000 0.997 0.003
I45.2 Bifascicular block
0.003 0.997 0.000
C91 Lymphoid leukaemia
0.003 0.997 0.000
I45.4 Nonspecific intraventricular block
0.003 0.997 0.000
M49.8 Spondylopathy in other diseases classified elsewhere
0.000 0.997 0.003
M49.4 Neuropathic spondylopathy
0.000 0.997 0.003
M49.3 Spondylopathy in other infectious and parasitic diseases classified elsewhere
0.000 0.997 0.003
M49.2 Enterobacterial spondylitis
0.000 0.997 0.003
M49.1 Brucella spondylitis
0.000 0.997 0.003
M49.0 Tuberculosis of spine
0.000 0.997 0.003
M49.56 Collapsed vertebra in diseases classified elsewhere (Lumbar region)
0.000 0.997 0.003
G70.0 Myasthenia gravis
0.003 0.997 0.000
K65.0 Acute peritonitis
0.000 0.997 0.003
C91.0 Acute lymphoblastic leukaemia
0.003 0.997 0.000
I45.9 Conduction disorder, unspecified
0.003 0.997 0.000
R22.9 Localised swelling, mass and lump, unspecified
0.000 0.997 0.003
Z75.9 Unspecified problem related to medical facilities and other health care
0.003 0.997 0.000
Z75.0 Medical services not available in home
0.003 0.997 0.000
Z75.3 Unavailability and inaccessibility of health-care facilities
0.003 0.997 0.000
T78 Adverse effects, not elsewhere classified
0.003 0.997 0.000
M49.50 Collapsed vertebra in diseases classified elsewhere (Multiple sites in spine)
0.000 0.997 0.003
M06.37 Rheumatoid nodule (Ankle and foot)
0.003 0.997 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.000 0.997 0.003
I45.8 Other specified conduction disorders
0.003 0.997 0.000
H34 Retinal vascular occlusions
0.000 0.997 0.003
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene
0.003 0.997 0.000
W25.8 Other specified place
0.003 0.997 0.000
I45.6 Preexcitation syndrome
0.003 0.997 0.000
I45.0 Right fascicular block
0.003 0.997 0.000
Z75.5 Holiday relief care
0.003 0.997 0.000
Z88.2 Personal history of allergy to sulphonamides
0.000 0.997 0.003
C91.4 Hairy-cell leukaemia
0.003 0.997 0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified
0.003 0.997 0.000
G61.9 Inflammatory polyneuropathy, unspecified
0.003 0.997 0.000
G61.1 Serum neuropathy
0.003 0.997 0.000
T31.0 Burns involving less than 10% of body surface
0.000 0.997 0.003
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.003 0.997 0.000
C91.9 Lymphoid leukaemia, unspecified
0.003 0.997 0.000
W25 Contact with sharp glass
0.003 0.997 0.000
I27.9 Pulmonary heart disease, unspecified
0.003 0.997 0.000
T78.0 Anaphylactic shock due to adverse food reaction
0.003 0.997 0.000
G30.9 Alzheimer's disease, unspecified
0.000 0.997 0.003
I78.0 Hereditary haemorrhagic telangiectasia
0.000 0.997 0.003
Z75.2 Other waiting period for investigation and treatment
0.002 0.997 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.002 0.997 0.000
C91.7 Other lymphoid leukaemia
0.002 0.997 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.002 0.997 0.000
C91.3 Prolymphocytic leukaemia
0.002 0.997 0.000
C91.2 Subacute lymphocytic leukaemia
0.002 0.997 0.000
H34.9 Retinal vascular occlusion, unspecified
0.000 0.997 0.003
T78.8 Other adverse effects, not elsewhere classified
0.003 0.997 0.000
M49.09 Tuberculosis of spine (Site unspecified)
0.000 0.997 0.002
M49.08 Tuberculosis of spine (Sacral and sacrococcygeal region)
0.000 0.997 0.002
M49.07 Tuberculosis of spine (Lumbosacral region)
0.000 0.997 0.002
M49.06 Tuberculosis of spine (Lumbar region)
0.000 0.997 0.002
M49.05 Tuberculosis of spine (Thoracolumbar region)
0.000 0.997 0.002
M49.04 Tuberculosis of spine (Thoracic region)
0.000 0.997 0.002
M49.03 Tuberculosis of spine (Cervicothoracic region)
0.000 0.997 0.002
M49.02 Tuberculosis of spine (Cervical region)
0.000 0.997 0.002
M49.01 Tuberculosis of spine (Occipito-atlanto-axial region)
0.000 0.997 0.002
M49.00 Tuberculosis of spine (Multiple sites in spine)
0.000 0.997 0.002
M49.19 Brucella spondylitis (Site unspecified)
0.000 0.997 0.002
M49.18 Brucella spondylitis (Sacral and sacrococcygeal region)
0.000 0.997 0.002
M49.17 Brucella spondylitis (Lumbosacral region)
0.000 0.997 0.002
M49.16 Brucella spondylitis (Lumbar region)
0.000 0.997 0.002
M49.15 Brucella spondylitis (Thoracolumbar region)
0.000 0.997 0.002
M49.14 Brucella spondylitis (Thoracic region)
0.000 0.997 0.002
M49.13 Brucella spondylitis (Cervicothoracic region)
0.000 0.997 0.002
M49.12 Brucella spondylitis (Cervical region)
0.000 0.997 0.002
M49.11 Brucella spondylitis (Occipito-atlanto-axial region)
0.000 0.997 0.002
M49.10 Brucella spondylitis (Multiple sites in spine)
0.000 0.997 0.002
M49.29 Enterobacterial spondylitis (Site unspecified)
0.000 0.997 0.002
M49.28 Enterobacterial spondylitis (Sacral and sacrococcygeal region)
0.000 0.997 0.002
M49.27 Enterobacterial spondylitis (Lumbosacral region)
0.000 0.997 0.002
M49.26 Enterobacterial spondylitis (Lumbar region)
0.000 0.997 0.002
M49.25 Enterobacterial spondylitis (Thoracolumbar region)
0.000 0.997 0.002
M49.24 Enterobacterial spondylitis (Thoracic region)
0.000 0.997 0.002
M49.23 Enterobacterial spondylitis (Cervicothoracic region)
0.000 0.997 0.002
M49.22 Enterobacterial spondylitis (Cervical region)
0.000 0.997 0.002
M49.21 Enterobacterial spondylitis (Occipito-atlanto-axial region)
0.000 0.997 0.002
M49.20 Enterobacterial spondylitis (Multiple sites in spine)
0.000 0.997 0.002
M49.39 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Site unspecified)
0.000 0.997 0.002
M49.38 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Sacral and sacrococcygeal region)
0.000 0.997 0.002
M49.37 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Lumbosacral region)
0.000 0.997 0.002
M49.36 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Lumbar region)
0.000 0.997 0.002
M49.35 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Thoracolumbar region)
0.000 0.997 0.002
M49.34 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Thoracic region)
0.000 0.997 0.002
M49.33 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Cervicothoracic region)
0.000 0.997 0.002
M49.32 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Cervical region)
0.000 0.997 0.002
M49.31 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Occipito-atlanto-axial region)
0.000 0.997 0.002
M49.30 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Multiple sites in spine)
0.000 0.997 0.002
M49.49 Neuropathic spondylopathy (Site unspecified)
0.000 0.997 0.002
M49.48 Neuropathic spondylopathy (Sacral and sacrococcygeal region)
0.000 0.997 0.002
M49.47 Neuropathic spondylopathy (Lumbosacral region)
0.000 0.997 0.002
M49.46 Neuropathic spondylopathy (Lumbar region)
0.000 0.997 0.002
M49.45 Neuropathic spondylopathy (Thoracolumbar region)
0.000 0.997 0.002
M49.44 Neuropathic spondylopathy (Thoracic region)
0.000 0.997 0.002
M49.43 Neuropathic spondylopathy (Cervicothoracic region)
0.000 0.997 0.002
M49.42 Neuropathic spondylopathy (Cervical region)
0.000 0.997 0.002
M49.41 Neuropathic spondylopathy (Occipito-atlanto-axial region)
0.000 0.997 0.002
M49.40 Neuropathic spondylopathy (Multiple sites in spine)
0.000 0.997 0.002
M49.89 Spondylopathy in other diseases classified elsewhere (Site unspecified)
0.000 0.997 0.002
M49.88 Spondylopathy in other diseases classified elsewhere (Sacral and sacrococcygeal region)
0.000 0.997 0.002
M49.87 Spondylopathy in other diseases classified elsewhere (Lumbosacral region)
0.000 0.997 0.002
M49.86 Spondylopathy in other diseases classified elsewhere (Lumbar region)
0.000 0.997 0.002
M49.85 Spondylopathy in other diseases classified elsewhere (Thoracolumbar region)
0.000 0.997 0.002
M49.84 Spondylopathy in other diseases classified elsewhere (Thoracic region)
0.000 0.997 0.002
M49.83 Spondylopathy in other diseases classified elsewhere (Cervicothoracic region)
0.000 0.997 0.002
M49.82 Spondylopathy in other diseases classified elsewhere (Cervical region)
0.000 0.997 0.002
M49.81 Spondylopathy in other diseases classified elsewhere (Occipito-atlanto-axial region)
0.000 0.997 0.002
M49.80 Spondylopathy in other diseases classified elsewhere (Multiple sites in spine)
0.000 0.997 0.002
M96.9 Postprocedural musculoskeletal disorder, unspecified
0.002 0.997 0.000
I78 Diseases of capillaries
0.000 0.997 0.003
M06.34 Rheumatoid nodule (Hand)
0.003 0.997 0.000
D41.1 Renal pelvis
0.002 0.997 0.000
M96.8 Other postprocedural musculoskeletal disorders
0.002 0.997 0.000
H34.2 Other retinal artery occlusions
0.000 0.997 0.002
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.003 0.997 0.000
T66-T78 Other and unspecified effects of external causes
0.003 0.997 0.000
T78.9 Adverse effect, unspecified
0.002 0.997 0.000
H35.8 Other specified retinal disorders
0.000 0.998 0.002
S20.3 Other superficial injuries of front wall of thorax
0.002 0.998 0.000
T71 Asphyxiation
0.002 0.998 0.000
M06.3 Rheumatoid nodule
0.002 0.998 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.002 0.998 0.000
M06.36 Rheumatoid nodule (Lower leg)
0.002 0.998 0.000
H34.0 Transient retinal artery occlusion
0.000 0.998 0.002
C84.5 Other and unspecified T-cell lymphomas
0.002 0.998 0.000
T70 Effects of air pressure and water pressure
0.002 0.998 0.000
C91.1 Chronic lymphocytic leukaemia
0.002 0.998 0.000
H34.1 Central retinal artery occlusion
0.000 0.998 0.002
K51.4 Pseudopolyposis of colon
0.002 0.998 0.000
M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis or bone plate
0.002 0.998 0.000
M96.5 Postradiation scoliosis
0.002 0.998 0.000
M96.4 Postsurgical lordosis
0.002 0.998 0.000
M96.3 Postlaminectomy kyphosis
0.002 0.998 0.000
M96.2 Postradiation kyphosis
0.002 0.998 0.000
E46 Unspecified protein-energy malnutrition
0.000 0.998 0.002
T68 Hypothermia
0.002 0.998 0.000
D41.9 Urinary organ, unspecified
0.002 0.998 0.000
D41.7 Other urinary organs
0.002 0.998 0.000
D41.3 Urethra
0.002 0.998 0.000
W25.6 Industrial and construction area
0.002 0.998 0.000
W25.5 Trade and service area
0.002 0.998 0.000
W25.1 Residential institution
0.002 0.998 0.000
W25.0 Home
0.002 0.998 0.000
W25.7 Farm
0.002 0.998 0.000
W25.4 Street and highway
0.002 0.998 0.000
W25.3 Sports and athletics area
0.002 0.998 0.000
W25.2 School, other institution and public administrative area
0.002 0.998 0.000
D73.0 Hyposplenism
0.002 0.998 0.000
T70.3 Caisson disease [decompression sickness]
0.002 0.998 0.000
M62.11 Other rupture of muscle (nontraumatic) (Shoulder region)
0.002 0.998 0.000
A41.2 Septicaemia due to unspecified staphylococcus
0.002 0.998 0.000
M96.1 Postlaminectomy syndrome, not elsewhere classified
0.002 0.998 0.000
D41.2 Ureter
0.002 0.998 0.000
S20.2 Contusion of thorax
0.002 0.998 0.000
T75 Effects of other external causes
0.002 0.998 0.000
H35.9 Retinal disorder, unspecified
0.000 0.998 0.002
G70 Myasthenia gravis and other myoneural disorders
0.002 0.998 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.002 0.998 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.002 0.998 0.000
G70.9 Myoneural disorder, unspecified
0.002 0.998 0.000
I78.9 Disease of capillaries, unspecified
0.000 0.998 0.002
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
0.002 0.998 0.000
K65 Peritonitis
0.000 0.998 0.002
T66 Unspecified effects of radiation
0.002 0.998 0.000
H52.3 Anisometropia and aniseikonia
0.002 0.998 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.002 0.998 0.000
C94 Other leukaemias of specified cell type
0.002 0.998 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.002 0.998 0.000
T74 Maltreatment syndromes
0.002 0.998 0.000
T73 Effects of other deprivation
0.002 0.998 0.000
T69 Other effects of reduced temperature
0.002 0.998 0.000
T67 Effects of heat and light
0.002 0.998 0.000
K65.9 Peritonitis, unspecified
0.000 0.998 0.002
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.002 0.998 0.000
T75.1 Drowning and nonfatal submersion
0.002 0.998 0.000
I27.0 Primary pulmonary hypertension
0.002 0.998 0.000
C95 Leukaemia of unspecified cell type
0.002 0.998 0.000
M06.39 Rheumatoid nodule (Site unspecified)
0.002 0.998 0.000
M06.38 Rheumatoid nodule (Other)
0.002 0.998 0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.002 0.998 0.000
M06.33 Rheumatoid nodule (Forearm)
0.002 0.998 0.000
M06.31 Rheumatoid nodule (Shoulder region)
0.002 0.998 0.000
I78.8 Other diseases of capillaries
0.000 0.998 0.002
N90.5 Atrophy of vulva
0.002 0.998 0.000
I27 Other pulmonary heart diseases
0.002 0.998 0.000
A87.9 Viral meningitis, unspecified
0.002 0.998 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.002 0.998 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.002 0.998 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.002 0.998 0.000
C84.3 Lymphoepithelioid lymphoma
0.002 0.998 0.000
C84.2 T-zone lymphoma
0.002 0.998 0.000
C84.1 Sezary's diease
0.002 0.998 0.000
I42.9 Cardiomyopathy, unspecified
0.000 0.998 0.002
C86 Other specified types of T/NK-cell lymphoma
0.002 0.998 0.000
T70.9 Effect of air pressure and water pressure, unspecified
0.002 0.998 0.000
T70.8 Other effects of air pressure and water pressure
0.002 0.998 0.000
T70.4 Effects of high-pressure fluids
0.002 0.998 0.000
T70.2 Other and unspecified effects of high altitude
0.002 0.998 0.000
T70.1 Sinus barotrauma
0.002 0.998 0.000
T70.0 Otitic barotrauma
0.002 0.998 0.000
M96.65 Fracture of pelvis following insertion of orthopedic implant, joint prosthesis, or bone plate (Fx pelvis following insrt ortho implnt/prosth/bone plt)
0.002 0.998 0.000
M96.63 Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate
0.002 0.998 0.000
C84.0 Mycosis fungoides
0.002 0.998 0.000
I27.8 Other specified pulmonary heart diseases
0.002 0.998 0.000
M95.4 Acquired deformity of chest and rib
0.002 0.998 0.000
O71.4 Obstetric high vaginal laceration alone
0.002 0.998 0.000
S20.0 Contusion of breast
0.002 0.998 0.000
M06.32 Rheumatoid nodule (Upper arm)
0.002 0.998 0.000
M06.30 Rheumatoid nodule (Multiple sites)
0.002 0.998 0.000
W25.09 Contact with sharp glass; Home; During unspecified activity
0.002 0.998 0.000
W25.03 Contact with sharp glass; Home; While engaged in other types of work
0.002 0.998 0.000
W25.18 Contact with sharp glass; Residential institution;While engaged in other specified activities
0.002 0.998 0.000
W25.52 Contact with sharp glass; Trade and service area;While working for income
0.002 0.998 0.000
W25.62 Contact with sharp glass; Industrial and construction area ;While working for income
0.002 0.998 0.000
C82.4 Follicular lymphoma grade IIIb
0.002 0.998 0.000
C93 Monocytic leukaemia
0.002 0.998 0.000
C84.4 Peripheral T-cell lymphoma
0.002 0.998 0.000
H57.1 Ocular pain
0.000 0.998 0.002
X78.0 Home
0.002 0.998 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.002 0.998 0.000
S20 Superficial injury of thorax
0.002 0.998 0.000
M62.15 Other rupture of muscle (nontraumatic) (Pelvic region and thigh)
0.002 0.998 0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified
0.002 0.998 0.000
M62.1 Other rupture of muscle (nontraumatic)
0.002 0.998 0.000
T75.8 Other specified effects of external causes
0.002 0.998 0.000
T75.3 Motion sickness
0.002 0.998 0.000
T75.2 Effects of vibration
0.002 0.998 0.000
T75.0 Effects of lightning
0.002 0.998 0.000
T86.0 Bone-marrow transplant rejection
0.000 0.998 0.002
C61 Malignant neoplasm of prostate
0.000 0.998 0.002
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)
0.002 0.998 0.000
C92 Myeloid leukaemia
0.002 0.998 0.000
H57 Other disorders of eye and adnexa
0.000 0.998 0.002
C92.9 Myeloid leukaemia, unspecified
0.002 0.998 0.000
G70.8 Other specified myoneural disorders
0.002 0.998 0.000
G70.2 Congenital and developmental myasthenia
0.002 0.998 0.000
G70.1 Toxic myoneural disorders
0.002 0.998 0.000
R44.0 Auditory hallucinations
0.002 0.998 0.000
M95 Other acquired deformities of musculoskeletal system and connective tissue
0.002 0.998 0.000
S52.00 Fracture of upper end of ulna (closed)
0.000 0.998 0.002
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.002 0.998 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.002 0.998 0.000
C85.0 Lymphosarcoma
0.002 0.998 0.000
C94.7 Other specified leukaemias
0.002 0.998 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.002 0.998 0.000
C94.5 Acute myelofibrosis
0.002 0.998 0.000
C94.4 Acute panmyelosis
0.002 0.998 0.000
C94.3 Mast cell leukaemia
0.002 0.998 0.000
C94.2 Acute megakaryoblastic leukaemia
0.002 0.998 0.000
C94.1 Chronic erythraemia
0.002 0.998 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.002 0.998 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.002 0.998 0.000
C96.8 Histiocytic sarcoma
0.002 0.998 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.002 0.998 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.002 0.998 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.002 0.998 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.002 0.998 0.000
C96.3 True histiocytic lymphoma
0.002 0.998 0.000
C96.2 Malignant mast cell tumour
0.002 0.998 0.000
C96.1 Malignant histiocytosis
0.002 0.998 0.000
C96.0 Letterer-Siwe disease
0.002 0.998 0.000
T67.9 Effects of heat and light, unspecified
0.002 0.998 0.000
T67.8 Other effects of heat and light
0.002 0.998 0.000
T67.7 Heat oedema
0.002 0.998 0.000
T67.6 Heat fatigue, transient
0.002 0.998 0.000
T67.5 Heat exhaustion, unspecified
0.002 0.998 0.000
T67.4 Heat exhaustion due to salt depletion
0.002 0.998 0.000
T67.3 Heat exhaustion, anhydrotic
0.002 0.998 0.000
T67.2 Heat cramp
0.002 0.998 0.000
T67.1 Heat syncope
0.002 0.998 0.000
T67.0 Heatstroke and sunstroke
0.002 0.998 0.000
T69.9 Effect of reduced temperature, unspecified
0.002 0.998 0.000
T69.8 Other specified effects of reduced temperature
0.002 0.998 0.000
T69.1 Chilblains
0.002 0.998 0.000
T69.0 Immersion hand and foot
0.002 0.998 0.000
T73.9 Effect of deprivation, unspecified
0.002 0.998 0.000
T73.8 Other effects of deprivation
0.002 0.998 0.000
T73.3 Exhaustion due to excessive exertion
0.002 0.998 0.000
T73.2 Exhaustion due to exposure
0.002 0.998 0.000
T73.1 Effects of thirst
0.002 0.998 0.000
T73.0 Effects of hunger
0.002 0.998 0.000
T74.9 Maltreatment syndrome, unspecified
0.002 0.998 0.000
T74.8 Other maltreatment syndromes
0.002 0.998 0.000
T74.3 Psychological abuse
0.002 0.998 0.000
T74.2 Sexual abuse
0.002 0.998 0.000
T74.1 Physical abuse
0.002 0.998 0.000
T74.0 Neglect or abandonment
0.002 0.998 0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis
0.002 0.998 0.000
C82.6 Cutaneous follicle centre lymphoma
0.002 0.998 0.000
C82.5 Diffuse follicle centre lymphoma
0.002 0.998 0.000
C95.0 Acute leukaemia of unspecified cell type
0.002 0.998 0.000
D41.4 Bladder
0.002 0.998 0.000
M95-M99 Other disorders of the musculoskeletal system and connective tissue
0.002 0.998 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.002 0.998 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.002 0.998 0.000
C95.7 Other leukaemia of unspecified cell type
0.002 0.998 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.002 0.998 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.002 0.998 0.000
C82.3 Follicular lymphoma grade IIIa
0.002 0.998 0.000
I27.1 Kyphoscoliotic heart disease
0.002 0.998 0.000
I70.00 Atherosclerosis of aorta (without gangrene)
0.000 0.998 0.002
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.001 0.998 0.000
C86.4 Blastic NK-cell lymphoma
0.001 0.998 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.001 0.998 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.001 0.998 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.001 0.998 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.001 0.998 0.000
O75.0 Maternal distress during labour and delivery
0.002 0.998 0.000
X23.9 Unspecified place
0.000 0.998 0.002
C55 Malignant neoplasm of uterus, part unspecified
0.000 0.998 0.002
D63 Anaemia in chronic diseases classified elsewhere
0.002 0.998 0.000
C92.4 Acute promyelocytic leukaemia
0.002 0.998 0.000
H52.1 Myopia
0.002 0.998 0.000
K65.8 Other peritonitis
0.000 0.998 0.002
C88 Malignant immunoproliferative diseases
0.002 0.998 0.000
T75.4 Effects of electric current
0.001 0.998 0.000
C90.1 Plasma cell leukaemia
0.002 0.998 0.000
S06.40 Epidural haemorrhage (without open intracranial wound)
0.000 0.998 0.002
S42.00 Fracture of clavicle (closed)
0.002 0.998 0.000
C82.2 Large cell, follicular
0.002 0.998 0.000
C82.0 Small cleaved cell, follicular
0.002 0.998 0.000
C90.3 Solitary plasmacytoma
0.002 0.998 0.000
C93.9 Monocytic leukaemia, unspecified
0.001 0.998 0.000
C93.7 Other monocytic leukaemia
0.001 0.998 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.001 0.998 0.000
C93.2 Subacute monocytic leukaemia
0.001 0.998 0.000
C93.0 Acute monocytic leukaemia
0.001 0.998 0.000
S20.4 Other superficial injuries of back wall of thorax
0.002 0.998 0.000
G04 Encephalitis, myelitis and encephalomyelitis
0.002 0.998 0.000
M46 Other inflammatory spondylopathies
0.000 0.998 0.001
T31 Burns classified according to extent of body surface involved
0.000 0.998 0.002
D73.5 Infarction of spleen
0.002 0.998 0.000
R41.1 Anterograde amnesia
0.002 0.998 0.000
S20.7 Multiple superficial injuries of thorax
0.001 0.998 0.000
H52 Disorders of refraction and accommodation
0.002 0.998 0.000
M46.18 Sacroiliitis, not elsewhere classified-Sacral/sacrococ
0.000 0.998 0.001
M62.19 Other rupture of muscle (nontraumatic) (Site unspecified)
0.001 0.998 0.000
M62.18 Other rupture of muscle (nontraumatic) (Other)
0.001 0.998 0.000
M62.17 Other rupture of muscle (nontraumatic) (Ankle and foot)
0.001 0.998 0.000
M62.16 Other rupture of muscle (nontraumatic) (Lower leg)
0.001 0.998 0.000
M62.14 Other rupture of muscle (nontraumatic) (Hand)
0.001 0.998 0.000
M62.13 Other rupture of muscle (nontraumatic) (Forearm)
0.001 0.998 0.000
M62.12 Other rupture of muscle (nontraumatic) (Upper arm)
0.001 0.998 0.000
M62.10 Other rupture of muscle (nontraumatic) (Multiple sites)
0.001 0.998 0.000
H52.2 Astigmatism
0.002 0.998 0.000
M46.1 Sacro-iliitis, not elsewhere classified
0.000 0.998 0.001
C25.9 Pancreas, unspecified
0.000 0.998 0.002
C86.5 Angioimmunoblastic T-cell lymphoma
0.001 0.998 0.000
C92.7 Other myeloid leukaemia
0.001 0.998 0.000
C95.9 Leukaemia, unspecified
0.001 0.998 0.000
H52.7 Disorder of refraction, unspecified
0.002 0.998 0.000
M99 Biomechanical lesions, not elsewhere classified
0.001 0.998 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.001 0.998 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.001 0.998 0.000
C92.5 Acute myelomonocytic leukaemia
0.001 0.998 0.000
C92.3 Myeloid sarcoma
0.001 0.998 0.000
C92.2 Subacute myeloid leukaemia
0.001 0.998 0.000
H30.9 Chorioretinal inflammation, unspecified
0.000 0.998 0.001
Y76.2 Prosthetic and other implants, materials and accessory devices
0.002 0.998 0.000
A87 Viral meningitis
0.002 0.998 0.000
I67.2 Cerebral atherosclerosis
0.000 0.998 0.002
M95.9 Acquired deformity of musculoskeletal system, unspecified
0.001 0.998 0.000
M95.8 Other specified acquired deformities of musculoskeletal system
0.001 0.998 0.000
M95.5 Acquired deformity of pelvis
0.001 0.998 0.000
M95.1 Cauliflower ear
0.001 0.998 0.000
S20.8 Superficial injuries of other and unspecified parts of thorax
0.002 0.998 0.000
H35 Other retinal disorders
0.000 0.998 0.002
C90.2 Plasmacytoma, extramedullary
0.001 0.998 0.000
H35.5 Hereditary retinal dystrophy
0.000 0.998 0.002
L98.9 Disorder of skin and subcutaneous tissue, unspecified
0.002 0.998 0.000
S12.70 Multiple fractures of cervical spine (closed)
0.001 0.998 0.000
H35.2 Other proliferative retinopathy
0.000 0.998 0.001
K35.9 Acute appendicitis, unspecified
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.